[HTML][HTML] A pilot study of omalizumab in eosinophilic esophagitis

D Loizou, B Enav, E Komlodi-Pasztor, P Hider… - PloS one, 2015 - journals.plos.org
Eosinophilic disorders of the gastrointestinal tract are an emerging subset of immune
pathologies within the spectrum of allergic inflammation. Eosinophilic Esophagitis (EoE), once …

Caspases and therapeutic potential of caspase inhibitors in moderate–severe SARS‐CoV‐2 infection and long COVID

…, M Latterich, P Mudd, A Spada, N Rindone, D Loizou… - Allergy, 2022 - Wiley Online Library
Background COVID‐19 can present with lymphopenia and extraordinary complex multiorgan
pathologies that can trigger long‐term sequela. Aims Given that inflammasome products, …

Validation of inducible basophil biomarkers: time, temperature and transportation

…, S Shayegan, B Enav, L Ispas, D Loizou… - Cytometry Part B …, 2021 - Wiley Online Library
Background The short stability window of several hours from blood collection to measuring
basophil activation has limited the use of flow cytometry‐based basophil activation assays in …

[HTML][HTML] Towards standardizing basophil identification by flow cytometry

SU Sonder, M Plassmeyer, D Loizou, O Alpan - Frontiers in Allergy, 2023 - frontiersin.org
Background: Basophils normally make up <2%of the white blood cells (WBC). There is no
clear consensus for basophil identification by flow cytometry. The increased demand for …

[HTML][HTML] STAT4 Phosphorylation of T-helper Cells predicts surgical outcomes in Refractory Chronic Rhinosinusitis

…, O Alpan, M Plassmeyer, L Kozhaya, D Loizou… - medRxiv, 2023 - ncbi.nlm.nih.gov
Objective: Chronic rhinosinusitis (CRS) impacts an estimated 5% to 15% of people worldwide,
incurring significant economic healthcare burden. There is a urgent need for the discovery …

Impact of immune work‐up on outcomes and the cost of care in patients with Chronic Rhinosinusitis.

O Alpan, D Loizou, I Santos, B Ness, J Plandowski - Allergy, 2019 - search.ebscohost.com
Chronic sinusitis (CRS) is a global medical problem afflicting 5%-15% of the world's population
depending on the geographical location, accounting for billions of dollars annually in …

Caspases in COVID-19 disease and sequela and the therapeutic potential of caspase inhibitors

…, M Latterich, P Mudd, A Spada, N Rindone, D Loizou… - medRxiv, 2020 - medrxiv.org
Currently, there is no effective vaccine and only one FDA approved early-stage therapy
against SARS-CoV-2 infection as an indication to prevent disease progression. Cellular …

Elucidating mechanisms of allergic inflammation in eosinophilic esophagitis

D Loizou, O Louis-Jacques, B Enav, J Kim… - Journal of Allergy and …, 2013 - jacionline.org
Methods We recruited 17 pediatric and adult subjects (ages between 12-75) with EoE (who
failed diet or steroid therapy) to receive omalizumab for 3 months. Improvement was …

Diffuse cutaneous mastocytosis, bullous variant, presenting in a six-month-old infant

…, B Molloy, V Nguyen, D Loizou… - The Journal of …, 2014 - jaci-inpractice.org
A 6-month-old boy was presented with a 1-month history of intermittent facial flushing and a
1-day history of erythematous wheal rash on his trunk. The wheals rapidly evolved into bullae…

CRS with Nasal Polyposis; Distinguishing Characteristics Through Immune-Phenotyping

…, A Roark, H Cade, M Kaufman, D Loizou… - Journal of Allergy and …, 2020 - jacionline.org
Methods We reviewed the charts of 23 patients with CRSwNP and 23 controls for serum IgE
levels, blood eosinophil counts and immune-phenotyping of lymphocyte subpopulations …